Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

430.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 500.00
  • 52 Week Low: 350.00
  • Currency: UK Pounds
  • Shares Issued: 47.68m
  • Volume: 52,528
  • Market Cap: £205.01m
  • RiskGrade: 180
  • Beta: 0.04

Numis starts coverage of Tristel at 'add'

By Michele Maatouk

Date: Thursday 25 May 2023

LONDON (ShareCast) - (Sharecast News) - Numis started coverage of Tristel on Thursday with an 'add' rating and 390p price target.
It said Tristel is a unique play within UK Medtech, offering high-level disinfectants, backed by a proprietary chemistry, used for the decontamination of medical devices and surfaces in hospitals.

"We think Tristel could more than double revenue and profits over five years, with the base business underpinned by diagnostic procedure demand, while potential US market expansion, pending FDA approval, represents a significant growth inflection point, which we believe is partly discounted," it said.

Numis said that optically, its multiple - circa 15x EV/EBITDA - is not particularly cheap, but should growth catalysts materialise, "we could see outer year multiples unwind".

"With the FDA decision pending (Jun-23), we account for some US optionality, setting our target price at 390p, and initiate with an add rating."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 430.00p
Change Today 10.00p
% Change 2.38 %
52 Week High 500.00
52 Week Low 350.00
Volume 52,528
Shares Issued 47.68m
Market Cap £205.01m
Beta 0.04
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.24% below the market average97.24% below the market average97.24% below the market average97.24% below the market average97.24% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
28.61% above the market average28.61% above the market average28.61% above the market average28.61% above the market average28.61% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Income
22.15% below the market average22.15% below the market average22.15% below the market average22.15% below the market average22.15% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
77.24% above the market average77.24% above the market average77.24% above the market average77.24% above the market average77.24% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Nov-24 21-Mar-24
Paid 20-Dec-24 12-Apr-24
Amount 8.28p 5.24p

Trades for 06-Nov-2024

Time Volume / Share Price
16:38 65 @ 430.00p
16:36 463 @ 430.00p
16:30 2,500 @ 428.50p
16:29 221 @ 430.00p
16:29 1,518 @ 430.00p

Tristel Key Personnel

Finance Director Elizabeth Dixon
CEO Matthew (Matt) Giovanni Sassone

Top of Page